Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000103623-23-000058
Filing Date
2023-12-14
Accepted
2023-12-14 13:53:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2704
  Complete submission text file 0000103623-23-000058.txt   4139
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Subject) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35280 | Film No.: 231486545
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTARES PHARMA, INC. 707 EAGLEVIEW BOULEVARD, SUITE 414 EXTON PA 19341
Business Address
Wotton Paul K (Reporting) CIK: 0001300997 (see all company filings)

Type: 144